- Precision BioSciences Inc Extraordinary Shareholders Meeting TranscriptJan 18, 2024
- Precision BioSciences Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Precision BioSciences Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 04, 2023
- Precision BioSciences Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Precision BioSciences Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Precision BioSciences Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Precision BioSciences Inc Announces In Vivo Gene Editing Collaboration with Novatris TranscriptJun 22, 2022
- Precision BioSciences Inc Allogeneic CAR T Update- Conference Call TranscriptJun 08, 2022
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Precision BioSciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Precision BioSciences Inc PBCAR0191 Clinical Data Call TranscriptJun 04, 2021
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2021
- Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call TranscriptApr 15, 2021
- Precision BioSciences Inc at Truist Securities Life Sciences Summit (April Series) TranscriptApr 13, 2021
- Precision BioSciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Cell Gene Meeting on the Mesa - Precision BioSciences TranscriptJan 08, 2021
- Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call TranscriptDec 04, 2020
- Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference Call TranscriptNov 20, 2020
Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Precision Biosciences In Vivo Gene Editing Collaboration with Lilly Conference Call.
(Operator Instructions)
I would now like to hand the conference over to you speaker today, Alex Kelly, Chief Corporate Affairs Officer. Please go ahead.
Thank you and good morning everyone and welcome to the Precision BioSciences webcast to announce our genome editing research collaboration and license agreement with Eli Lilly.
I'm Alex Kelly and I'm the Chief Corporate Affairs Officer for Precision BioSciences. And before we begin, I'd like to remind you that some of the statements regarding Precision's future expectations, beliefs, intentions, goals, strategies, plans or prospects are considered forward-looking statements within meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements including without limitation statements regarding the expected benefits of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)